Which physiological parameter is commonly used to assess short-term improvement after starting inhaled therapy?

Which physiological parameter is commonly used to assess short-term improvement after starting inhaled therapy?

• A. Decrease in oxygen saturation
• B. Change in FEV1 or peak expiratory flow rate
• C. Increase in inspiratory time
• D. Change in tidal volume

Answer: (B)

When assessing a short-term response to inhaled therapy, the key idea is that bronchodilators improve airway caliber, which shows up as better expiratory airflow. FEV1 measures how much air you can forcibly exhale in one second, and peak expiratory flow rate gauges the strongest speed of exhalation. Both directly reflect how open the airways are and how easily air can leave the lungs. After starting inhaled treatment, especially a fast-acting bronchodilator, these expiratory flow measures typically rise quickly, signaling that obstruction has lessened. Oxygen saturation, while important for overall oxygenation, is not a sensitive or specific short-term marker of bronchodilator response. Changes in inspiratory time or tidal volume are more about breathing pattern and effort than about the degree of airway narrowing, so they don’t reliably indicate whether the airways have opened. So, the best indicator of immediate improvement is a change in expiratory airflow, captured by FEV1 or peak expiratory flow rate. In practice, a meaningful bronchodilator response is seen as an increase in FEV1 (often a significant percentage and usually a minimum volume threshold) and a corresponding rise in peak flow measurements.

When assessing a short-term response to inhaled therapy, the key idea is that bronchodilators improve airway caliber, which shows up as better expiratory airflow. FEV1 measures how much air you can forcibly exhale in one second, and peak expiratory flow rate gauges the strongest speed of exhalation. Both directly reflect how open the airways are and how easily air can leave the lungs. After starting inhaled treatment, especially a fast-acting bronchodilator, these expiratory flow measures typically rise quickly, signaling that obstruction has lessened.

Oxygen saturation, while important for overall oxygenation, is not a sensitive or specific short-term marker of bronchodilator response. Changes in inspiratory time or tidal volume are more about breathing pattern and effort than about the degree of airway narrowing, so they don’t reliably indicate whether the airways have opened.

So, the best indicator of immediate improvement is a change in expiratory airflow, captured by FEV1 or peak expiratory flow rate. In practice, a meaningful bronchodilator response is seen as an increase in FEV1 (often a significant percentage and usually a minimum volume threshold) and a corresponding rise in peak flow measurements.